Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
07 2023
Historique:
received: 10 11 2021
accepted: 17 05 2023
medline: 7 7 2023
pubmed: 30 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Axonal degeneration determines the clinical outcome of multiple sclerosis and is thought to result from exposure of denuded axons to immune-mediated damage. Therefore, myelin is widely considered to be a protective structure for axons in multiple sclerosis. Myelinated axons also depend on oligodendrocytes, which provide metabolic and structural support to the axonal compartment. Given that axonal pathology in multiple sclerosis is already visible at early disease stages, before overt demyelination, we reasoned that autoimmune inflammation may disrupt oligodendroglial support mechanisms and hence primarily affect axons insulated by myelin. Here, we studied axonal pathology as a function of myelination in human multiple sclerosis and mouse models of autoimmune encephalomyelitis with genetically altered myelination. We demonstrate that myelin ensheathment itself becomes detrimental for axonal survival and increases the risk of axons degenerating in an autoimmune environment. This challenges the view of myelin as a solely protective structure and suggests that axonal dependence on oligodendroglial support can become fatal when myelin is under inflammatory attack.

Identifiants

pubmed: 37386131
doi: 10.1038/s41593-023-01366-9
pii: 10.1038/s41593-023-01366-9
pmc: PMC10322724
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1218-1228

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s).

Références

Trapp, B. D. & Nave, K.-A. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247–269 (2008).
pubmed: 18558855
Kornek, B. et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157, 267–276 (2000).
pubmed: 10880396 pmcid: 1850217
Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J. & Brück, W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125, 2202–2212 (2002).
pubmed: 12244078
Dziedzic, T. et al. Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol. 20, 976–985 (2010).
pubmed: 20477831 pmcid: 8094657
Nikić, I. et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17, 495–499 (2011).
pubmed: 21441916
Sorbara, C. D. et al. Pervasive axonal transport deficits in multiple sclerosis models. Neuron 84, 1183–1190 (2014).
pubmed: 25433639
Witte, M. E. et al. Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis. Neuron 101, 615–624.e5 (2019).
pubmed: 30686733 pmcid: 6389591
Romanelli, E. et al. Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model. Nat. Commun. 7, 13275 (2016).
pubmed: 27848954 pmcid: 5116090
Stassart, R. M., Möbius, W., Nave, K. A. & Edgar, J. M. The axon–myelin unit in development and degenerative disease. Front. Neurosci. 12, 467 (2018).
pubmed: 30050403 pmcid: 6050401
Nave, K. A. Myelination and support of axonal integrity by glia. Nature 468, 244–252 (2010).
pubmed: 21068833
Edgar, J. M. et al. Río-Hortega’s drawings revisited with fluorescent protein defines a cytoplasm-filled channel system of CNS myelin. J. Anat. 239, 1241–1255 (2021).
pubmed: 34713444 pmcid: 8602028
Fünfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517–521 (2012).
pubmed: 22622581 pmcid: 3613737
Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443–448 (2012).
pubmed: 22801498 pmcid: 3408792
Mukherjee, C. et al. Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metab. 32, 259–272.e10 (2020).
pubmed: 32531201 pmcid: 7116799
Kassmann, C. M. et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39, 969–976 (2007).
pubmed: 17643102
Lappe-Siefke, C. et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33, 366–374 (2003).
pubmed: 12590258
Griffiths, I. et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610–1613 (1998).
pubmed: 9616125
Gallyas, F., Pál, J., Farkas, O. & Dóczi, T. The fate of axons subjected to traumatic ultrastructural (neurofilament) compaction: an electron-microscopic study. Acta Neuropathol. 111, 229–237 (2006).
pubmed: 16485106
Lampert, P. W. A comparative electron microscopic study of reactive, degenerating, regenerating, and dystrophic axons. J. Neuropathol. Exp. Neurol. 26, 345–368 (1967).
pubmed: 5229871
Edgar, J. M., Smith, R. S. & Duncan, I. D. Transmission electron microscopy and morphometry of the CNS white matter. Methods Mol. Biol. 2143, 233–261 (2020).
pubmed: 32524485
Saggu, S. K., Chotaliya, H. P., Blumbergs, P. C. & Casson, R. J. Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study. BMC Neurosci. 11, 97 (2010).
pubmed: 20707883 pmcid: 2930628
Hasegawa, M., Rosenbluth, J. & Ishise, J. Nodal and paranodal structural changes in mouse and rat optic nerve during Wallerian degeneration. Brain Res. 452, 345–357 (1988).
pubmed: 3401741
Narciso, M. S., Hokoç, J. N. & Martinez, A. M. B. Watery and dark axons in Wallerian degeneration of the opossum’s optic nerve: different patterns of cytoskeletal breakdown? An. Acad. Bras. Cienc. 73, 230–243 (2001).
Lyons, J.-A., San, M., Happ, M. P. & Cross, A. H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29, 3432–3439 (1999).
pubmed: 10556797
Edgar, J. M. et al. Early ultrastructural defects of axons and axon–glia junctions in mice lacking expression of Cnp1. Glia 57, 1815–1824 (2009).
pubmed: 19459211
Snaidero, N. et al. Antagonistic functions of MBP and CNP establish cytosolic channels in CNS myelin. Cell Rep. 18, 314–323 (2017).
pubmed: 28076777 pmcid: 5263235
Falcão, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837–1844 (2018).
pubmed: 30420755 pmcid: 6544508
Meijer, M. et al. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron 110, 1193–1210.e13 (2022).
pubmed: 35093191 pmcid: 9810341
Moore, S. et al. A role of oligodendrocytes in information processing. Nat. Commun. 11, 5497 (2020).
pubmed: 33127910 pmcid: 7599337
Moran, A. E. et al. T cell receptor signal strength in T
pubmed: 21606508 pmcid: 3173240
Pohl, H. B. F. et al. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 31, 1069–1080 (2011).
pubmed: 21248132 pmcid: 6632929
Oluich, L. J. et al. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J. Neurosci. 32, 8317–8330 (2012).
pubmed: 22699912 pmcid: 6703635
Edgar, J. M. et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166, 121–131 (2004).
pubmed: 15226307 pmcid: 2172145
Edgar, J. M. et al. Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol. Med. 2, 42–50 (2010).
pubmed: 20091761 pmcid: 3377270
Chamberlain, K. A. et al. Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2. Neuron 109, 3456–3472.e8 (2021).
pubmed: 34506725 pmcid: 8571020
Saab, A. S. et al. Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91, 119–132 (2016).
pubmed: 27292539 pmcid: 9084537
Snaidero, N. et al. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156, 277–290 (2014).
pubmed: 24439382 pmcid: 4862569
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2018).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772
Bittner, S., Afzali, A. M., Wiendl, H. & Meuth, S. G. Myelin oligodendrocyte glycoprotein (MOG
Berghoff, S. A. et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat. Neurosci. 24, 47–60 (2021).
pubmed: 33349711
Bosch-Queralt, M. et al. Diet-dependent regulation of TGFβ impairs reparative innate immune responses after demyelination. Nat. Metab. 3, 211–227 (2021).
pubmed: 33619376 pmcid: 7610359
Bosch-Queralt, M. et al. A fluorescence microscopy-based protocol for volumetric measurement of lysolecithin lesion-associated de- and re-myelination in mouse brain. STAR Protoc. 3, 101141 (2022).
pubmed: 35141565 pmcid: 8810560
Belevich, I., Joensuu, M., Kumar, D., Vihinen, H. & Jokitalo, E. Microscopy Image Browser: a platform for segmentation and analysis of multidimensional datasets. PLoS Biol. 14, e1002340 (2016).
pubmed: 26727152 pmcid: 4699692
Liu, L. et al. Dissociation of microdissected mouse brain tissue for artifact free single-cell RNA sequencing. STAR Protoc. 2, 100590 (2021).
pubmed: 34159323 pmcid: 8196224
Marsh, S. E. et al. Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat. Neurosci. 25, 306–316 (2022).
pubmed: 35260865
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotech. 36, 411–420 (2018).
Blighe, K. & Lun, A. PCAtools: everything principal components analysis. GitHub https://github.com/kevinblighe/PCAtools (2019).
Waltman, L. & van Eck, N. J. A smart local moving algorithm for large-scale modularity-based community detection. Eur. Phys. J. 86, 471 (2013).
McInnes, L., Healy, J., Saul, N. & Großberger, L. UMAP: Uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452 pmcid: 4944528
Yamakita, Y. et al. Fascin1 promotes cell migration of mature dendritic cells. J. Immunol. 186, 2850–2859 (2011).
pubmed: 21263068
Amorim, A. et al. IFNγ and GM-CSF control complementary differentiation programs in the monocyte-to-phagocyte transition during neuroinflammation. Nat. Immunol. 23, 217–228 (2022).
pubmed: 35102344
Rasouli, J. et al. A distinct GM-CSF
pubmed: 33097590
Gaublomme, J. T. et al. Single-cell genomics unveils critical regulators of Th17 cell pathogenicity. Cell 163, 1400–1412 (2015).
pubmed: 26607794 pmcid: 4671824
Ajami, B. et al. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat. Neurosci. 21, 541–551 (2018).
pubmed: 29507414 pmcid: 8629134
Riol-Blanco, L. et al. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 174, 4070–4080 (2005).
pubmed: 15778365
Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281–6298.e23 (2021).
pubmed: 34875227 pmcid: 8900676
Jordão, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).
pubmed: 30679343
Giladi, A. et al. Cxcl10
pubmed: 32313246

Auteurs

Erik Schäffner (E)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Mar Bosch-Queralt (M)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Julia M Edgar (JM)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Maria Lehning (M)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Judith Strauß (J)

Institute of Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.

Niko Fleischer (N)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Theresa Kungl (T)

Institute of Anatomy, Leipzig University, Leipzig, Germany.

Peter Wieghofer (P)

Institute of Anatomy, Leipzig University, Leipzig, Germany.
Cellular Neuroanatomy, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.

Stefan A Berghoff (SA)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Tilo Reinert (T)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.
Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Martin Krueger (M)

Institute of Anatomy, Leipzig University, Leipzig, Germany.

Markus Morawski (M)

Paul Flechsig Institute of Brain Research, Leipzig University, Leipzig, Germany.

Wiebke Möbius (W)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.

Alonso Barrantes-Freer (A)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Jens Stieler (J)

Paul Flechsig Institute of Brain Research, Leipzig University, Leipzig, Germany.

Ting Sun (T)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.

Gesine Saher (G)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.

Markus H Schwab (MH)

Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany.

Christoph Wrede (C)

Institute of Functional and Applied Anatomy, Research Core Unit Electron Microscopy, Hannover Medical School, Hannover, Germany.

Maximilian Frosch (M)

Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.

Marco Prinz (M)

Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Centre for NeuroModulation (NeuroModBasics), University of Freiburg, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.

Daniel S Reich (DS)

Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Alexander Flügel (A)

Institute of Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.

Christine Stadelmann (C)

Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.

Robert Fledrich (R)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. Robert.Fledrich@medizin.uni-leipzig.de.
Institute of Anatomy, Leipzig University, Leipzig, Germany. Robert.Fledrich@medizin.uni-leipzig.de.

Klaus-Armin Nave (KA)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. nave@mpinat.mpg.de.

Ruth M Stassart (RM)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. Ruth.Stassart@medizin.uni-leipzig.de.
Paul Flechsig Institute of Neuropathology, University Clinic Leipzig, Leipzig, Germany. Ruth.Stassart@medizin.uni-leipzig.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH